The shrinking lung syndrome in systemic lupus erythematosus: improvement with corticosteroid therapy.
Respiratory manifestations of systemic lupus erythematosus (SLE) are frequent. The 'shrinking lung syndrome' (SLS) represents a rare complication of SLE. The pathogenesis and therapy of the SLS remains controversial. We report a series of five consecutive cases with the SLS of which we provide a detailed description of the extent and dynamics of the response to corticosteroid therapy.
Oud
K T M
KT
Pulmonology Department, Division of Clinical Immunology & Rheumatology, Academic Medical Centre, Amsterdam, The Netherlands.
Bresser
P
P
ten Berge
R J M
RJ
Jonkers
R E
RE
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000328:Adult; D005260:Female; D006801:Humans; D008171:Lung Diseases / Q000188:drug therapy* / Q000209:etiology; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000188:drug therapy; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D011239:Prednisolone / Q000627:therapeutic use; D013577:Syndrome
D000305:Adrenal Cortex Hormones; D011239:Prednisolone; D008775:Methylprednisolone